GH Research (GHRS)

GH Research (GHRS) Stock Price & Analysis


GHRS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.70 - $17.41
Previous Close$11.2
Average Volume (3M)74.99K
Market Cap
Enterprise Value$401.07M
Total Cash (Recent Filing)$165.96M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-21.1
Sep 21, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding52,020,000
10 Day Avg. Volume66,444
30 Day Avg. Volume74,992
Standard Deviation0.17
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit13.13
Enterprise Value/Ebitda-49.64
Price Target Upside233.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5




What was GH Research’s price range in the past 12 months?
GH Research lowest stock price was $5.70 and its highest was $17.41 in the past 12 months.
    What is GH Research’s market cap?
    Currently, no data Available
    When is GH Research’s upcoming earnings report date?
    GH Research’s upcoming earnings report date is Sep 21, 2023 which is in 112 days.
      How were GH Research’s earnings last quarter?
      GH Research released its earnings results on May 11, 2023. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.216 by $0.006.
        Is GH Research overvalued?
        According to Wall Street analysts GH Research’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does GH Research pay dividends?
          GH Research does not currently pay dividends.
          What is GH Research’s EPS estimate?
          GH Research’s EPS estimate is -$0.24.
            How many shares outstanding does GH Research have?
            GH Research has 52,020,847 shares outstanding.
              What happened to GH Research’s price movement after its last earnings report?
              GH Research reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.216. Following the earnings report the stock price went up 3.564%.
                Which hedge fund is a major shareholder of GH Research?
                Among the largest hedge funds holding GH Research’s share is RA Capital Management. It holds GH Research’s shares valued at 45M.


                  GH Research Stock Smart Score

                  The GH Research stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  GH Research

                  GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.


                  Top 5 ETFs holding GHRS

                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold GHRS. The ETFs are listed according to market value of GHRS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Jazz Pharmaceuticals
                  Perrigo Company
                  Avadel Pharmaceuticals
                  Mallinckrodt public limited company

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis